Cargando…
Vaccine‐induced immune thrombotic thrombocytopenia presenting with normal platelet count
Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out by the absence of thrombocytopenia. We report on three patients...
Autores principales: | Page, David, Zhu, Nancy, Sawler, Daniel, Sun, Hao Wei, Turley, Elona, Pai, Menaka, Wu, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440941/ https://www.ncbi.nlm.nih.gov/pubmed/34532632 http://dx.doi.org/10.1002/rth2.12596 |
Ejemplares similares
-
Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022) -
Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
por: Bang, Soo-Mee, et al.
Publicado: (2021) -
Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022) -
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021) -
Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022)